Company intelligence / Profile preview

Zeenome

Malaga, Andalusia, Spainzeenome.ir ↗

Ownership: Private
Development stage: Commercial

Overview

Zeenome provides AI-powered, personalized longevity plans based on blood tests. Customers receive custom pill packs tailored to their needs, with progress tracked over time. There are no published clinical trial results; the offering is a consumer-facing wellness service rather than a regulated therapeutic pipeline[1][4].

Modalities: Personalized supplement packs (nutraceuticals)Digital health/AI-driven recommendations
Industry: Food & Nutrition

Beyond the preview

Go deeper on Zeenome.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zeenome.

Explore the full profile